Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Accretive Health, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Accretive Health, Inc. (“Accretive Health” or the “Company”) (NYSE: AH).
The investigation focuses on Accretive Health’s February 26, 2013 announcement that it will postpone the release of its financial results for the fourth quarter and full year 2012 because it is evaluating the timing of revenue recognition for its revenue cycle management agreements. Furthermore, the Company stated that it is evaluating its method of revenue recognition, and it may be required to restate prior-period financial statements.
If you invested in Accretive Health stock or options between May 9, 2012 and February 26, 2013 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org or email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Accretive Health’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
369 Lexington Avenue 10th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.